Ticker Scorecard - JANX Basics Company: Janux Therapeutics, Inc. IPO Date: June 11, 2021 Sector: Healthcare Industry: Biotech Market Cap: $2.11B Activated in VL: True Average Daily Range Avg Daily Range: $0.87 | 3.82% Avg Daily Range (30 D): $1.70 | 3.84% Avg Daily Range (90 D): $1.57 | 3.14% Institutional Daily Volume Avg Daily Volume: .28M Avg Daily Volume (30 D): .93M Avg Daily Volume (90 D): .88M Trade Size Avg Trade Size (Sh.): 69 Avg Trade Size (Sh.) (30 D): 66 Avg Trade Size (Sh.) (90 D): 65 Institutional Trades Total Inst.Trades: 989 Avg Inst. Trade: $2.36M Avg Inst. Trade (30 D): $2.14M Avg Inst. Trade (90 D): $2.51M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $3.81M Avg Closing Trade (30 D): $4.31M Avg Closing Trade (90 D): $5.13M Avg Closing Volume: 88.49K     News Dec 4, 2024 @ 11:23 PM Why Janux Therapeutics Crushed the Market Today Source: Eric Volkman May 30, 2024 @ 3:01 PM The Latest Analyst Ratings For Janux Therapeutics Source: Benzinga Insights May 13, 2024 @ 1:00 PM Analyst Ratings For Janux Therapeutics Source: Benzinga Insights May 7, 2024 @ 12:15 PM Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q1 Los... Source: Zacks Equity Research Apr 30, 2024 @ 12:50 PM Here's What Could Help Janux Therapeutics (JANX) M... Source: Zacks Equity Research Financials   TTM Q3 2024 Q2 2024 Basic EPS $-1.17 $-.51 $-.11 Diluted EPS $-1.17 $-.51 $-.11 Revenue $ 13.05M $ .44M $ 8.9M Gross Profit $ $ $ Net Income / Loss $ -60.54M $ -28.06M $ -5.96M Operating Income / Loss $ -85.96M $ -35.84M $ -13.82M Cost of Revenue $ $ $ Net Cash Flow $ 9.6M $ 12.09M $ -198.14M PE Ratio